Five-minute point-of-care testing for SARS-CoV-2: Not there yet.
作者信息
Hogan Catherine A, Sahoo Malaya K, Huang ChunHong, Garamani Natasha, Stevens Bryan, Zehnder James, Pinsky Benjamin A
机构信息
Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA; Clinical Virology Laboratory, Stanford Health Care, Stanford, CA, USA.
Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
出版信息
J Clin Virol. 2020 Jul;128:104410. doi: 10.1016/j.jcv.2020.104410. Epub 2020 May 1.
Abstract
摘要
相似文献
1
Five-minute point-of-care testing for SARS-CoV-2: Not there yet.针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的五分钟即时检测：尚未实现。
J Clin Virol. 2020 Jul;128:104410. doi: 10.1016/j.jcv.2020.104410. Epub 2020 May 1.
2
Evaluation of a Rapid Diagnostic Assay for Detection of SARS-CoV-2 Antigen in Nasopharyngeal Swabs.用于检测鼻咽拭子中SARS-CoV-2抗原的快速诊断检测方法的评估
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.00977-20.
3
Is Nasopharyngeal Swab Comparable With Nasopharyngeal Aspirate to Detect SARS-CoV-2 in Children?鼻咽拭子与鼻咽抽吸物在检测儿童新型冠状病毒方面具有可比性吗？
Pediatr Infect Dis J. 2020 Sep;39(9):e288-e289. doi: 10.1097/INF.0000000000002824.
4
Test Agreement between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold Ranges.罗氏Cobas 6800与赛沛GeneXpert Xpress SARS-CoV-2检测在高循环阈值范围内的检测一致性
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.01187-20.
5
Selecting a SARS-CoV-2/COVID Molecular Testing Method for Your Laboratory.为您的实验室选择一种SARS-CoV-2/新冠病毒分子检测方法。
J Appl Lab Med. 2020 Jul 1;5(4):837-840. doi: 10.1093/jalm/jfaa076.
6
Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays.使用赛沛Xpert Xpress SARS-CoV-2检测系统和罗氏cobas SARS-CoV-2检测法检测严重急性呼吸综合征冠状病毒2（SARS-CoV-2）
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.00772-20.
7
The Challenges of Expanding Rapid Tests to Curb COVID-19.扩大快速检测以遏制新冠疫情面临的挑战
JAMA. 2020 Nov 10;324(18):1813-1815. doi: 10.1001/jama.2020.21106.
8
Comparison of the Accula SARS-CoV-2 Test with a Laboratory-Developed Assay for Detection of SARS-CoV-2 RNA in Clinical Nasopharyngeal Specimens.Accula SARS-CoV-2 检测与实验室自建检测在临床鼻咽拭子标本中检测 SARS-CoV-2 RNA 的比较。
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.01072-20.
9
Comparison of Abbott ID Now and Abbott m2000 Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Symptomatic Patients.雅培ID Now与雅培m2000方法用于检测有症状患者鼻咽拭子和鼻拭子中新型冠状病毒的比较。
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.00798-20.
10
Special Issue on Diagnostic Testing for Severe Acute Respiratory Syndrome Coronavirus 2 and Lessons from This Pandemic.严重急性呼吸综合征冠状病毒2诊断检测特刊及本次大流行的经验教训
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.01324-20.
引用本文的文献
1
Fast and Sensitive Detection of SARS-CoV-2 Nucleic Acid Using a Rapid Detection System Free of RNA Extraction.使用无RNA提取的快速检测系统快速灵敏地检测新型冠状病毒2核酸
Int J Anal Chem. 2023 Jan 20;2023:8053524. doi: 10.1155/2023/8053524. eCollection 2023.
2
Sensibility and Specificity of the VitaPCR™ SARS-CoV-2 Assay for the Rapid Diagnosis of COVID-19 in Older Adults in the Emergency Department.VitaPCR™ SARS-CoV-2 检测用于急诊科老年 COVID-19 快速诊断的敏感性和特异性。
Viruses. 2023 Jan 9;15(1):189. doi: 10.3390/v15010189.
3
Competitive SNP-LAMP probes for rapid and robust single-nucleotide polymorphism detection.竞争性 SNP-LAMP 探针用于快速、稳健的单核苷酸多态性检测。
Cell Rep Methods. 2022 Jun 13;2(7):100242. doi: 10.1016/j.crmeth.2022.100242. eCollection 2022 Jul 18.
4
Abbott® ID NOW™ COVID-19 rapid molecular assay versus Hologic® Panther Aptima™ SARS-CoV-2 assay in nasopharyngeal specimens: results from 1-year retrospective study in an emergency department.雅培® ID NOW™ COVID-19 快速分子检测与豪洛捷® Panther Aptima™ SARS-CoV-2 检测在鼻咽标本中的比较：急诊科为期 1 年的回顾性研究结果。
Diagn Microbiol Infect Dis. 2022 Sep;104(1):115742. doi: 10.1016/j.diagmicrobio.2022.115742. Epub 2022 Jun 12.
5
Considerations for the selection of tests for SARS-CoV-2 molecular diagnostics.SARS-CoV-2 分子诊断检测选择的考虑因素。
Mol Biol Rep. 2022 Oct;49(10):9725-9735. doi: 10.1007/s11033-022-07455-5. Epub 2022 Apr 20.
6
Pre-evaluation assessment of serological-based COVID-19 point-of-care lateral flow assays in Kenya.肯尼亚基于血清学的新冠病毒即时检测侧向流动分析方法的预评估
Afr J Lab Med. 2021 Sep 17;10(1):1317. doi: 10.4102/ajlm.v10i1.1317. eCollection 2021.
7
Review of Current COVID-19 Diagnostics and Opportunities for Further Development.当前新型冠状病毒肺炎诊断方法综述及进一步发展机遇
Front Med (Lausanne). 2021 May 7;8:615099. doi: 10.3389/fmed.2021.615099. eCollection 2021.
8
Clinical laboratory evaluation of COVID-19.新型冠状病毒肺炎的临床实验室评估
Clin Chim Acta. 2021 Aug;519:172-182. doi: 10.1016/j.cca.2021.04.022. Epub 2021 Apr 30.
9
Diagnostic accuracy of the Cepheid Xpert Xpress and the Abbott ID NOW assay for rapid detection of SARS-CoV-2: A systematic review and meta-analysis.Cepheid Xpert Xpress 和 Abbott ID NOW 检测试剂盒快速检测 SARS-CoV-2 的诊断准确性：系统评价和荟萃分析。
J Med Virol. 2021 Jul;93(7):4523-4531. doi: 10.1002/jmv.26994. Epub 2021 May 3.
10
Infection precautions for severe acute respiratory syndrome coronavirus 2 in assisted reproduction centers: dodging an invisible bullet.辅助生殖中心严重急性呼吸综合征冠状病毒 2 感染防护：躲避无形之弹。
Fertil Steril. 2021 Apr;115(4):831-839. doi: 10.1016/j.fertnstert.2021.01.016. Epub 2021 Jan 14.
本文引用的文献
1
Comparison of the Panther Fusion and a laboratory-developed test targeting the envelope gene for detection of SARS-CoV-2.比较 Panther Fusion 和一种针对包膜基因的实验室开发的检测 SARS-CoV-2 的试验。
J Clin Virol. 2020 Jun;127:104383. doi: 10.1016/j.jcv.2020.104383. Epub 2020 Apr 24.
2
Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Individuals Diagnosed with COVID-19.雅培ID Now、索林集团Simplexa以及美国疾病控制与预防中心（CDC）和美国食品药品监督管理局（FDA）紧急使用授权方法用于从确诊为COVID-19的个体的鼻咽拭子和鼻拭子中检测严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的比较
J Clin Microbiol. 2020 Jul 23;58(8). doi: 10.1128/JCM.00760-20.
Zotero 插件